07:40 AM EDT, 04/25/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) reported a Q1 non-GAAP loss Thursday of $4.40 per diluted share, compared with non-GAAP earnings of $2.05 a year earlier.

Analysts surveyed by Capital IQ expected a normalized loss of $4.42.

Revenue for the quarter ended March 31 was $11.87 billion, compared with $11.34 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.45 billion.

The company said it expects 2024 non-GAAP EPS of $0.40 to $0.70. Analysts polled by Capital IQ expect $0.66.

Shares of Bristol-Myers Squibb ( BMY ) were down more than 1% in recent premarket activity on Thursday.

Price: 48.03, Change: -0.83, Percent Change: -1.70